Related Experiment Video
Updated: Feb 8, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer
Yang Lan1, Xuewei Xiao1, Zhengchi He1
1Center for Functional Genomics and Bioinformatics, Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610065, Sichuan, P.R. China.
Abstract:
Overexpressed in colon carcinoma-1 (OCC-1) is one of the earliest annotated long noncoding RNAs (lncRNAs) in colorectal cancer (CRC); however, its function remains largely unknown. Here, we revealed that OCC-1 plays a tumor suppressive role in CRC. OCC-1 knockdown by RNA interference promotes cell growth both in vitro and in vivo, which is largely due to its ability to inhibit G0 to G1 and G1 to S phase cell cycle transitions. In addition, overexpression of OCC-1 can suppress cell growth in OCC-1 knockdown cells. OCC-1 exerts its function by binding to and destabilizing HuR (ELAVL1), a cancer-associated RNA binding protein (RBP) which can bind to and stabilize thousands of mRNAs. OCC-1 enhances the binding of ubiquitin E3 ligase β-TrCP1 to HuR and renders HuR susceptible to ubiquitination and degradation, thereby reducing the levels of HuR and its target mRNAs, including the mRNAs directly associated with cancer cell growth. These findings reveal that lncRNA OCC-1 can regulate the levels of a large number of mRNAs at post-transcriptional level through modulating RBP HuR stability.
Insights
Long noncoding RNA OCC-1 suppresses colorectal cancer (CRC) by targeting HuR. OCC-1 destabilizes HuR, reducing cell growth and regulating cell cycle transitions, revealing its tumor-suppressive role in CRC.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Colorectal cancer (CRC) is a major global health concern.
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- The specific function of overexpressed in colon carcinoma-1 (OCC-1) lncRNA in CRC remains largely uncharacterized.
Purpose of the Study:
- To elucidate the functional role of OCC-1 in colorectal cancer.
- To investigate the molecular mechanisms by which OCC-1 influences CRC progression.
Main Methods:
- RNA interference (RNAi) for OCC-1 knockdown.
- In vitro and in vivo cell growth assays.
- Analysis of cell cycle phase transitions.
- Investigation of protein-protein interactions using ubiquitination assays.
- Western blotting to assess protein levels.
Main Results:
- OCC-1 exhibits a tumor-suppressive function in CRC.
- Knockdown of OCC-1 promotes cell proliferation and inhibits G0/G1 and G1/S phase transitions.
- Overexpression of OCC-1 suppresses cell growth.
- OCC-1 binds to and destabilizes HuR (ELAVL1), a cancer-associated RNA binding protein.
- OCC-1 facilitates HuR ubiquitination and degradation via β-TrCP1, reducing HuR and target mRNA levels.
Conclusions:
- lncRNA OCC-1 acts as a tumor suppressor in colorectal cancer.
- OCC-1 regulates cancer cell growth by modulating HuR stability at the post-transcriptional level.
- This mechanism involves enhancing HuR ubiquitination and degradation, impacting downstream target mRNAs crucial for cell growth.
More Related Videos
07:35Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
Published on: December 1, 2023
06:49Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Related Concept Videos
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
RNA Stability
Destabilization of Microtubules
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Drugs that Destabilize Microtubules